34 results
Page 2 of 2
8-K
EX-99.1
kol14uhqkt1njcybchi
13 Oct 22
Invivyd Appoints Fred Driscoll as Interim Chief Financial Officer and Announces Resource Reallocation to Maximize Integrated Discovery
4:16pm
S-3
f87s46wphp7ruw9c
28 Sep 22
Shelf registration
5:08pm
8-K
EX-99.1
joy0fe
12 Sep 22
Adagio Therapeutics Announces Corporate Name Change to Invivyd
7:46am
8-K
EX-99.3
ho8diwo3tvk8iob8aef
12 Sep 22
Adagio Therapeutics Announces Corporate Name Change to Invivyd
7:46am
8-K
EX-99.2
okbmamb 52yg5
12 Sep 22
Adagio Therapeutics Announces Corporate Name Change to Invivyd
7:46am
10-K
rcwlx3jlxrrb4yyjkx1u
31 Mar 22
Annual report
8:18am
8-K
EX-99.1
clspxnm510
14 Dec 21
Adagio Therapeutics Reports Reduction in In Vitro Neutralizing Activity of ADG20 Against Omicron SARS-CoV-2 Variant
9:10am
8-K
8dblg2 21
29 Nov 21
Regulation FD Disclosure
8:23am
8-K
EX-99.1
w4gmwhstkwzcd8
29 Nov 21
Regulation FD Disclosure
8:23am
424B4
cqy r60zwi
6 Aug 21
Prospectus supplement with pricing info
4:54pm
S-1/A
d0whb4a2oo9p
2 Aug 21
IPO registration (amended)
6:20am
S-1
0vr0u1km tqlj
16 Jul 21
IPO registration
4:56pm
DRS/A
djmqjykx216t6vit
28 Jun 21
Draft registration statement (amended)
12:00am
DRS
wpfmhgag5kt
21 May 21
Draft registration statement
12:00am